Brush Beam Improves Prototyping with 3D Printing
The explosive success of 3D printing is finding applications in a new area for prototyping and manufacturing: dentistry. Beam Brush, whose main claim-to-fame includes the recent release of the first blue chip-embedded toothbrush to track healthy brushing habits, is effectively shaking up the medical device supply chain while netting huge savings.
“We wanted to build a stand for our toothbrush because early customers had started asking for one,” Beam Brush cofounder Alex Fromeyer said in an interview. An innovative answer came in the form of 3D printing. Now, he said, “we are one of the first consumer medical device companies to use 3D printers and one of the first companies to own the Replicator 2.”
Beam Brush, the World’s First Smart Toothbrush
This move allows the digital health startup a huge amount of flexibility and independence from start to finish.
“We didn’t have to engage the mold maker at a cost to us because we were 90% of the way there,” said Fromeyer, explaining the mold maker simply transferred the spec from the MakerBot format to its software after the initial design had been finalized in-house. “We also built our own supply chain and we do packaging and fulfillment.”
Beam Brush has now extended the process to make manufacturing and assembling brushes more efficient.
Image Sourced via Flickr: Creative Tools
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”